SOMERVILLE, Mass., June 26, 2025 /PRNewswire/ -- Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that the ...
Company to highlight outlook for pipeline and platform momentum in 2026 Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results